Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) SHH

28.32

+0.34(+1.22%)

Updated at August 19 09:40AM

Currency In CNY

Valuation

Market Cap11.25B
Enterprise Value8.35B
P/E Ratio22.97
PEG Ratio28.25
Price/Sales Ratio3.27
Price/Book Ratio2.87
Enterprise/Revenue2.82
Enterprise/EBITDA15.26

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.14
Operating Margin0.18

Management Effectiveness

Return On Assets0.1
Return On Equity0.13

Income Statement

Revenue3.73B
Revenue/Share8.63
Gross Profit1.74B
EBITDA745.93M
Net Income528.09M
Diluted EPS1.23

Balance Sheet

Total Cash2.92B
Total Cash/Share6.73
Total Debt89.07M
Total Debt/Equity0.02
Current Ratio4.6
Book Value Per Share10.18

Price History

52-Week Change5.44
52-Week High31.46
52-Week Low21.33
Moving Average 50 Days28.24
Moving Average 200 Days26.47

Statistics

Average Volume5.89M
Shares Outstanding431.05M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.62
Trailing Annual Dividend Yield2.19
Payout Ratio0.33
Last Split Factor13:10
Last Split DateJuly 21, 2015